Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Please Try Again

Password Hint : {{passwordHint}}

Remember me

Bullboard - Stock Discussion Forum CASI Pharmaceuticals Inc CASI

Healthcare Biotechnology

CASI Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutics and pharmaceutical products in China, the United States, and throughout the world. The Company is focused on acquiring, developing, and commercializing products that augment its hematology oncology therapeutic focus as well as other areas of unmet medical need. Its... see more

Add To Watchlist

Bullboard (NDAQ:CASI)

View:

Post by whytestockson Sep 04, 2024 9:47pm

CASI PHARMACEUTICALS TO PARTICIPATE IN THE 2024 H.C. WAINWRI

JUST IN: $CASI CASI PHARMACEUTICALS TO PARTICIPATE IN THE 2024 H.C. WAINWRIGHT GLOBAL INVESTMENT CONFERENCECASI PHARMACEUTICALS TO PARTICIPATE IN THE 2024 H.C. WAINWRIGHT GLOBAL INVESTMENT CONFERENCE ...more

126

Post by MikeTesteron Aug 01, 2024 4:48pm

CASI Pharmaceuticals Faces Headwinds, but Promising Pipeline

https://beyondspx.com/2024/08/01/casi-pharmaceuticals-faces-headwinds-but-promising-pipeline-offers-hope/

Lahontan Gold Announces Filing of Santa Fe Technical Report

posted Nov 29, 2024 9:00am by Lahontan Gold Corp.

Lahontan Gold is pleased to announce that the Company has filed on SEDAR+ an independent Technical Report and updated Mineral Resource Estimate ("MRE") titled "Santa Fe Project Technical Report," effective October 9, 2024, and dated November 27, 2024, for Lahontan's Santa Fe Mine gold and silver project, Santa Fe District, Mineral County, Nevada. ...read more

Post by whytestockson Mar 05, 2024 2:00pm

CASI Pharmaceuticals Blood Cancer Drug Shows Encouraging Cli

News; $CASI CASI Pharmaceuticals Blood Cancer Drug Shows Encouraging Clinical Efficacy In Chinese Patients | BenzingaCASI Pharmaceuticals Inc@(NASDAQ:CASI) and@BioInvent International AB@announced ...more

The Market Update

< Previous bulletin

Next bulletin >

A daily snapshot of everything
from market open to close.

< Previous

Next >

Dealroom for high-potential pre-IPO opportunities

Become a member today, It's free!

Sign In

Send my password